News12 New York
Where to Watch
Download the App
Local
Crime
Weather
beWell
The East End
Crime Files

Addiction expert says 'fentanyl backlash' is impacting chronic pain patients

The U.S. Drug Enforcement Agency (DEA) says an illicit form of fentanyl is being manufactured overseas and funneled into the U.S. for sale on the street, where it's killing people at a staggering rate.

Frank Recchia

Aug 25, 2024, 9:36 PM

Updated

Share:

More Stories

A Bridgeport addiction expert says the fentanyl epidemic is making it difficult for people who genuinely need the drug to get it.

"Fentanyl has long been the gold standard for treating severe chronic pain -- but cancer patients and other people who genuinely need this potent analgesic are being turned away by pharmacies and doctors," said John Hamilton, CEO of Liberation Programs, a Bridgeport nonprofit whose mission is to help people struggling with addiction.

"With so many people dying as a result of fentanyl, many doctors and pharmacies just don't want the headache of dealing with it outside of a hospital setting," Hamilton said.

The U.S. Drug Enforcement Agency (DEA) says an illicit form of fentanyl is being manufactured overseas and funneled into the U.S. for sale on the street, where it's killing people at a staggering rate.

But the prescription form of fentanyl continues to be used as a reliable and highly effective treatment for post-surgical and chronic intractable pain, Hamilton said.

"I've been taking fentanyl legally and properly for decades, and it's the only drug that works for me," said Raven Smith, of Bridgeport, who is being treated by a doctor in New York for severe chronic pain.

"The problem is no pharmacy wants to deal with me because of all the baggage that comes with fentanyl nowadays," Smith said.

Hamilton says this "fentanyl backlash" is yet another tragic consequence of the fentanyl epidemic.

More Stories

More From News12

App StoreGoogle Play Store

info

Newsletter

Send Photos/Videos

Contact

About Us

News Team

News 12 New York

follow us

Twitter

Facebook

Instagram

more resources

Optimum Corporate

Optimum Service

Advertise on News 12

Careers

Content Removal Policy

© 2026 N12N, LLC

Privacy Policy

Terms of Service

Ad Choices